Fortress Biotech, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fortress Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q3 2024.
  • Fortress Biotech, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$4.53M, a 243% decline year-over-year.
  • Fortress Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$17M, a 265% decline year-over-year.
  • Fortress Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was -$11.3M, a 14.1% decline from 2022.
  • Fortress Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was -$9.9M, a 141% decline from 2021.
  • Fortress Biotech, Inc. annual Nonoperating Income (Expense) for 2021 was $24.2M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$17M -$4.53M -$7.71M -243% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$9.31M -$1.04M +$8.16M +88.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$17.5M -$2.46M -$6.18M -166% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$11.3M -$8.99M -$6.63M -281% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$4.66M $3.18M +$5.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$10.2M -$9.2M -$6.19M -206% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$3.97M $3.72M +$5.93M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$9.9M -$2.36M -$71K -3.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$9.83M -$2.33M -$6.39M -157% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.44M -$3M -$21.5M -116% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $18M -$2.21M -$6.16M -156% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $24.2M -$2.29M -$6.24M -158% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $30.4M $4.06M +$11M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $19.4M $18.5M +$21.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.09M $3.95M +$6.49M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$8.58M $3.95M +$6.52M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$15.1M -$6.92M -$4.49M -185% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$10.6M -$3.07M -$877K -40% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$9.73M -$2.54M -$18.9M -116% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $9.16M -$2.57M -$163K -6.76% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $9.32M -$2.43M +$595K +19.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $8.73M -$2.19M +$1.21M +35.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $7.52M $16.4M +$18.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$10.8M -$2.41M +$4.86M +66.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$15.7M -$3.03M +$679K +18.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$16.3M -$3.4M -$3.64M -1492% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$12.7M -$1.97M -$4.99M -165% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$7.72M -$7.27M -$5.21M -252% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$2.51M -$3.7M -$2.99M -422% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $484K $244K +$1.5M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.01M $3.02M +$4.57M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$5.58M -$2.07M +$384K +15.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$5.96M -$710K +$1.07M +60.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$7.04M -$1.25M -$2.6M -193% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$4.44M -$1.55M -$1.09M -234% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$3.35M -$2.45M -$3.7M -296% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $345K -$1.78M -$1.54M -625% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.88M $1.34M +$1.29M +2485% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $590K -$464K +$324K +41.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $266K $1.25M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$246K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $52K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$788K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.